WO2024201420 - MIRNA-484 INHIBITORS AND USES THEREOF
National phase entry is expected:
Publication Number
WO/2024/201420
Publication Date
03.10.2024
International Application No.
PCT/IB2024/053115
International Filing Date
29.03.2024
Title **
[English]
MIRNA-484 INHIBITORS AND USES THEREOF
[French]
INHIBITEURS DE MIARN-484 ET LEURS UTILISATIONS
Applicants **
BIORCHESTRA CO., LTD.
2F-216, Venture-dong, KRIBB, 125, Gwahak-ro
Yuseong-gu
Daejeon 34141, KR
SK BIOPHARMACEUTICALS CO., LTD.
221, Pangyoyeok-ro, Bundang-Gu
Seongnam
Gyeonggi-do 13494, KR
Inventors
RYU, Jin-Hyeob
c/o BIORCHESTRA CO., LTD.
2F-216, Venture-dong, KRIBB, 125, Gwahak-ro
Yuseong-gu
Daejeon 34141, KR
JANG, Ha Na
c/o BIORCHESTRA CO., LTD.
2F-216, Venture-dong, KRIBB, 125, Gwahak-ro
Yuseong-gu
Daejeon 34141, KR
LIM, Jongyeob
c/o BIORCHESTRA CO., LTD.
2F-216, Venture-dong, KRIBB, 125, Gwahak-ro
Yuseong-gu
Daejeon 34141, KR
JUNG, Yeon-Joo
c/o BIORCHESTRA CO., LTD.
2F-216, Venture-dong, KRIBB, 125, Gwahak-ro
Yuseong-gu
Daejeon 34141, KR
PARK, Young Jin
c/o BIORCHESTRA CO., LTD.
2F-216, Venture-dong, KRIBB, 125, Gwahak-ro
Yuseong-gu
Daejeon 34141, KR
KIM, Insun
c/o BIORCHESTRA CO., LTD.
2F-216, Venture-dong, KRIBB, 125, Gwahak-ro
Yuseong-gu
Daejeon 34141, KR
LIM, Yu Na
c/o BIORCHESTRA CO., LTD.
2F-216, Venture-dong, KRIBB, 125, Gwahak-ro
Yuseong-gu
Daejeon 34141, KR
KANG, Howon
c/o SK BIOPHARMACEUTICALS CO., LTD.
221, Pangyoyeok-ro, Bundang-gu
Seongnam
Gyeonggi-do 13494, KR
JOUNG, Chanmi
c/o SK BIOPHARMACEUTICALS CO., LTD.
221, Pangyoyeok-ro, Bundang-gu
Seongnam
Gyeonggi-do 13494, KR
CHOI, Eunju
c/o SK BIOPHARMACEUTICALS CO., LTD.
221, Pangyoyeok-ro, Bundang-gu
Seongnam
Gyeonggi-do 13494, KR
PARK, Ah Hyung
c/o SK BIOPHARMACEUTICALS CO., LTD.
221, Pangyoyeok-ro, Bundang-gu
Seongnam
Gyeonggi-do 13494, KR
YOOK, Chaehyun
c/o SK BIOPHARMACEUTICALS CO., LTD.
221, Pangyoyeok-ro, Bundang-gu
Seongnam
Gyeonggi-do 13494, KR
CHO, Seokhwan
c/o SK BIOPHARMACEUTICALS CO., LTD.
221, Pangyoyeok-ro, Bundang-gu
Seongnam
Gyeonggi-do 13494, KR
SHIN, Yujin
c/o SK BIOPHARMACEUTICALS CO., LTD.
221, Pangyoyeok-ro, Bundang-gu
Seongnam
Gyeonggi-do 13494, KR
GIL, So-Young
c/o SK BIOPHARMACEUTICALS CO., LTD.
221, Pangyoyeok-ro, Bundang-gu
Seongnam
Gyeonggi-do 13494, KR
Priority Data
63/493,526
31.03.2023
US
Quotation for National Phase entry
Abstract[English]
The present disclosure includes the use of a miR-484 inhibitor for treating a disease or disorder associated with the increased level of miR-484. In some aspects, the miR-484 inhibitor is capable of reducing the expression of a gene and/or protein associated with miR-484.[French]
La présente invention comprend l'utilisation d'un inhibiteur de miR-484 pour traiter une maladie ou un trouble associé au niveau accru de miR-484. Selon certains aspects, l'inhibiteur de miR-484 est capable de réduire l'expression d'un gène et/ou d'une protéine associés à miR-484.